Search research articles
Contact Us
Filters
Showing results (11-20 of 164) with videos related to
Page
of 17
Sort By:
Annales De Pathologie
|
August 12, 2003
[An uncommon and misleading neoplasm to know!]
Guillaume Granier, Pierre Feugier, Cyrille Hulin, et al.
Leukemia & Lymphoma
|
August 23, 2011
Post-remission intervention with alemtuzumab or rituximab to eradicate minimal residual disease in chronic lymphocytic leukemia: where do we stand?
Eric Van Den Neste, Rémi Letestu, Thérèse Aurran-Schleinitz, et al.
Experimental Hematology
|
February 21, 2007
Human mesenchymal stem cells improve ex vivo expansion of adult human CD34+ peripheral blood progenitor cells and decrease their allostimulatory capacity
Na Li, Pierre Feugier, Brigitte Serrurrier, et al.
Clinical Case Reports
|
September 28, 2020
Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count
Marion Divoux, Alexia Plocque, Margaux Sevin, et al.
Journal of Clinical Medicine
|
November 11, 2022
Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma
Esther Hazane Leroyer, Caroline Ziegler, Charline Moulin, et al.
Frontiers in Immunology
|
December 31, 2020
Microenvironment Remodeling and Subsequent Clinical Implications in Diffuse Large B-Cell Histologic Variant of Richter Syndrome
Hélène Augé, Anne-Béatrice Notarantonio, Romain Morizot, et al.
Annales De Biologie Clinique
|
February 4, 2022
[Investigation of large granular lymphocytic leukemias: data from the laboratory of hematology at Nancy University Hospital, France]
Charles Guisnel, Jean-François Lesesve, Delphine Gérard, et al.
Leukemia & Lymphoma
|
April 6, 2011
Quality of life in 269 patients with poor-risk diffuse large B-cell lymphoma treated with rituximab versus observation after autologous stem cell transplant
Natacha Heutte, Corinne Haioun, Pierre Feugier, et al.
Journal of Hematotherapy & Stem Cell Research
|
February 16, 2002
Ex vivo expansion of stem and progenitor cells in co-culture of mobilized peripheral blood CD34+ cells on human endothelium transfected with adenovectors expressing thrombopoietin, c-kit ligand, and Flt-3 ligand
Pierre Feugier, Deog Yeon Jo, Jae Hung Shieh, et al.
Cancers
|
August 10, 2024
Phase IB Study of Oral Selinexor in Combination with Rituximab and Platinum Chemotherapy in Patients with Relapsed/Refractory B-Cell Lymphoma-Final Analysis
Marie Maerevoet, Olivier Casasnovas, Guillaume Cartron, et al.
Page
of 17
Search research articles
Search
Showing results (11-20 of 164) with videos related to
Sort By:
Page
of 17
Annales De Pathologie
|
August 12, 2003
[An uncommon and misleading neoplasm to know!]
Guillaume Granier, Pierre Feugier, Cyrille Hulin, et al.
Leukemia & Lymphoma
|
August 23, 2011
Post-remission intervention with alemtuzumab or rituximab to eradicate minimal residual disease in chronic lymphocytic leukemia: where do we stand?
Eric Van Den Neste, Rémi Letestu, Thérèse Aurran-Schleinitz, et al.
Experimental Hematology
|
February 21, 2007
Human mesenchymal stem cells improve ex vivo expansion of adult human CD34+ peripheral blood progenitor cells and decrease their allostimulatory capacity
Na Li, Pierre Feugier, Brigitte Serrurrier, et al.
Clinical Case Reports
|
September 28, 2020
Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count
Marion Divoux, Alexia Plocque, Margaux Sevin, et al.
Journal of Clinical Medicine
|
November 11, 2022
Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma
Esther Hazane Leroyer, Caroline Ziegler, Charline Moulin, et al.
Frontiers in Immunology
|
December 31, 2020
Microenvironment Remodeling and Subsequent Clinical Implications in Diffuse Large B-Cell Histologic Variant of Richter Syndrome
Hélène Augé, Anne-Béatrice Notarantonio, Romain Morizot, et al.
Annales De Biologie Clinique
|
February 4, 2022
[Investigation of large granular lymphocytic leukemias: data from the laboratory of hematology at Nancy University Hospital, France]
Charles Guisnel, Jean-François Lesesve, Delphine Gérard, et al.
Leukemia & Lymphoma
|
April 6, 2011
Quality of life in 269 patients with poor-risk diffuse large B-cell lymphoma treated with rituximab versus observation after autologous stem cell transplant
Natacha Heutte, Corinne Haioun, Pierre Feugier, et al.
Journal of Hematotherapy & Stem Cell Research
|
February 16, 2002
Ex vivo expansion of stem and progenitor cells in co-culture of mobilized peripheral blood CD34+ cells on human endothelium transfected with adenovectors expressing thrombopoietin, c-kit ligand, and Flt-3 ligand
Pierre Feugier, Deog Yeon Jo, Jae Hung Shieh, et al.
Cancers
|
August 10, 2024
Phase IB Study of Oral Selinexor in Combination with Rituximab and Platinum Chemotherapy in Patients with Relapsed/Refractory B-Cell Lymphoma-Final Analysis
Marie Maerevoet, Olivier Casasnovas, Guillaume Cartron, et al.
Page
of 17